Phillip P. Sharp

6.8k total citations
15 papers, 402 citations indexed

About

Phillip P. Sharp is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Phillip P. Sharp has authored 15 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Hematology. Recurrent topics in Phillip P. Sharp's work include Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Ubiquitin and proteasome pathways (4 papers). Phillip P. Sharp is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Ubiquitin and proteasome pathways (4 papers). Phillip P. Sharp collaborates with scholars based in Australia, United States and China. Phillip P. Sharp's co-authors include Christopher J. Burns, Jean‐Marc Garnier, Martin G. Banwell, Anthony C. Willis, Carl R. Walkley, Scott Taylor, Nicole C. Walsh, Ankita Gupte, Andrew C.W. Zannettino and Emma K. Baker and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Phillip P. Sharp

15 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip P. Sharp Australia 11 292 127 104 45 16 15 402
Jin-Yi Zhu United States 8 357 1.2× 82 0.6× 148 1.4× 54 1.2× 18 1.1× 8 428
Matthew Lindon United Kingdom 9 292 1.0× 80 0.6× 107 1.0× 58 1.3× 9 0.6× 11 393
Suhong Pang United States 11 281 1.0× 181 1.4× 57 0.5× 58 1.3× 11 0.7× 13 477
George Lund United Kingdom 7 247 0.8× 52 0.4× 54 0.5× 38 0.8× 24 1.5× 12 367
Chun-Hwa Chen Taiwan 10 211 0.7× 103 0.8× 64 0.6× 92 2.0× 11 0.7× 11 363
Peter G. K. Clark United Kingdom 7 353 1.2× 51 0.4× 149 1.4× 63 1.4× 16 1.0× 7 398
Weiqiong Zuo China 14 316 1.1× 181 1.4× 44 0.4× 78 1.7× 20 1.3× 21 522
Cindy Palmer United States 8 158 0.5× 67 0.5× 57 0.5× 40 0.9× 16 1.0× 10 275
Teresa A.F. Cardote United Kingdom 9 379 1.3× 132 1.0× 62 0.6× 77 1.7× 36 2.3× 9 495
Maryanna E. Lanning United States 13 388 1.3× 199 1.6× 67 0.6× 77 1.7× 10 0.6× 15 472

Countries citing papers authored by Phillip P. Sharp

Since Specialization
Citations

This map shows the geographic impact of Phillip P. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip P. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip P. Sharp more than expected).

Fields of papers citing papers by Phillip P. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip P. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip P. Sharp. The network helps show where Phillip P. Sharp may publish in the future.

Co-authorship network of co-authors of Phillip P. Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip P. Sharp. A scholar is included among the top collaborators of Phillip P. Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip P. Sharp. Phillip P. Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Meyer, Lauren K., Cristina Delgado-Martín, Phillip P. Sharp, et al.. (2022). Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 198(1). 137–141. 6 indexed citations
2.
Sharp, Phillip P., et al.. (2021). Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents. Journal of Medicinal Chemistry. 64(5). 2436–2465. 19 indexed citations
3.
Bolte, Benoît, Christopher S. Bryan, Phillip P. Sharp, et al.. (2019). Total Syntheses of the 3H-Pyrrolo[2,3-c]quinolone-Containing Alkaloids Marinoquinolines A–F, K, and Aplidiopsamine A Using a Palladium-Catalyzed Ullmann Cross-Coupling/Reductive Cyclization Pathway. The Journal of Organic Chemistry. 85(2). 650–663. 16 indexed citations
4.
Sharp, Phillip P., Junming Ho, Elizabeth H. Krenske, et al.. (2018). Mechanistic Studies on the Base-Promoted Conversion of Alkoxy-Substituted, Ring-Fused gem-Dihalocyclopropanes into Furans: Evidence for a Process Involving Electrocyclic Ring Closure of a Carbonyl Ylide Intermediate. The Journal of Organic Chemistry. 83(22). 13678–13690. 5 indexed citations
5.
Wang, Siyao, Leo Corcilius, Phillip P. Sharp, & Richard J. Payne. (2017). Synthesis of a GlcNAcylated arginine building block for the solid phase synthesis of death domain glycopeptide fragments. Bioorganic & Medicinal Chemistry. 25(11). 2895–2900. 8 indexed citations
6.
Sharp, Phillip P., Jean‐Marc Garnier, Tamás Hatfaludi, et al.. (2017). Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors. ACS Medicinal Chemistry Letters. 8(12). 1298–1303. 24 indexed citations
7.
Xu, Zhen, Phillip P. Sharp, Yuan Yao, et al.. (2016). BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. Leukemia. 30(7). 1531–1541. 25 indexed citations
8.
Wang, Siyao, Leo Corcilius, Phillip P. Sharp, et al.. (2016). Synthesis of rhamnosylated arginine glycopeptides and determination of the glycosidic linkage in bacterial elongation factor P. Chemical Science. 8(3). 2296–2302. 23 indexed citations
9.
Baker, Emma K., Scott Taylor, Ankita Gupte, et al.. (2015). BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. Scientific Reports. 5(1). 10120–10120. 92 indexed citations
10.
Hawkins, Bill C., Lisa Lindqvist, Phillip P. Sharp, et al.. (2014). Simplified Silvestrol Analogues with Potent Cytotoxic Activity. ChemMedChem. 9(7). 1556–1566. 16 indexed citations
11.
Sharp, Phillip P., Jean‐Marc Garnier, David C.S. Huang, & Christopher J. Burns. (2014). Evaluation of functional groups as acetyl-lysine mimetics for BET bromodomain inhibition. MedChemComm. 5(12). 1834–1842. 21 indexed citations
13.
Garnier, Jean‐Marc, Phillip P. Sharp, & Christopher J. Burns. (2013). BET bromodomain inhibitors: a patent review. Expert Opinion on Therapeutic Patents. 24(2). 185–199. 78 indexed citations
14.
Sharp, Phillip P.. (2011). Q&A: Phillip Sharp on Biomedical Convergence. Cancer Discovery. 1(5). 370–370. 1 indexed citations
15.
Foot, Jonathan S., et al.. (2006). Dichlorocarbene adducts of alkyl enol ethers as precursors to furans: application to a total synthesis of the furanosesquiterpene (±)-pallescensin A. Tetrahedron Letters. 47(38). 6817–6820. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026